Coming Full Circle: How a Patient Worked With a Breast Cancer Drug Years Before Reclassification of Her Disease Led to the Same Treatment

A patient with metastatic breast cancer shares how she learned that her disease was recently reclassified as HER-2 low, and what it was like to first learn about the FDA-approved drug years before she would be prescribed the treatment.